Questions: Inflammatory Response and Wound Healing Repair

Question 1

A diabetic patient has a non-healing leg ulcer that has been open for three months. Biopsy shows abundant neutrophils, elevated pro-inflammatory cytokines, and minimal collagen deposition. Which phase of wound healing has failed to transition, and what cellular failure likely explains this?

• A. Hemostasis has failed; insufficient platelet aggregation means the fibrin scaffold never forms
• B. The inflammatory phase has failed to resolve; macrophages have not switched from pro-inflammatory to reparative phenotype, preventing the transition to proliferation
• C. The proliferation phase has stalled; fibroblasts are unable to deposit collagen due to hypoxia
• D. The remodeling phase has failed; type III collagen cannot be converted to type I collagen

Answer: (B)

The biopsy findings — abundant neutrophils, elevated pro-inflammatory cytokines, and minimal collagen — indicate the wound is stuck in the inflammatory phase. The pivotal transition from inflammation to proliferation is the macrophage phenotype switch: macrophages must shift from releasing pro-inflammatory cytokines (IL-1, TNF-α) to releasing reparative growth factors (VEGF, FGF) that recruit fibroblasts and initiate angiogenesis. In diabetic wounds, this switch is impaired, keeping the wound in a chronic inflammatory state. Without reparative macrophages, fibroblast recruitment and collagen deposition cannot begin.

Question 2

A wound has progressed past the hemostasis phase. What two key roles do macrophages play that make them the 'conductors' of the subsequent repair process?

• A. Macrophages form the fibrin clot and release PDGF to recruit fibroblasts
• B. Macrophages clear debris via phagocytosis and, after switching to a reparative phenotype, release VEGF and FGF to trigger angiogenesis and fibroblast migration
• C. Macrophages deposit the initial type III collagen scaffold and direct epithelial cell migration across the wound surface
• D. Macrophages release complement proteins and antibodies that neutralize bacterial infection, preventing wound contamination

Answer: (B)

Macrophages arrive after the initial neutrophil response and take over the inflammatory phase. Their dual role is what makes them central: they continue debris clearance (phagocytosis), then critically switch phenotype to release VEGF (driving angiogenesis — new capillary sprouting) and FGF (recruiting fibroblasts for collagen deposition). This phenotype switch is the key transition from inflammatory to proliferative phase. Neutrophils handle the early bacterial clearance; macrophages bridge between destruction (inflammation) and construction (proliferation).

Question 3

Fully healed scar tissue reaches only about 70-80% of original skin tensile strength because the repair process replaces damaged tissue with scar rather than regenerating the original tissue architecture.

• T. True
• F. False

Answer: True

This reflects a fundamental limitation of mammalian wound repair: it is a repair process, not a regenerative one. The original skin architecture (organized collagen bundles, appendages like hair follicles and sweat glands, optimal collagen cross-linking patterns) is not reconstructed. Instead, the wound is filled with scar tissue — a simplified matrix with less organized collagen that reaches approximately 70-80% of original tensile strength even after months of remodeling. Some organisms (salamanders, zebrafish) can regenerate tissues completely, but mammalian skin heals by scarring.

Question 4

During the proliferation phase of wound healing, type I collagen is deposited first because it is the strongest collagen and needed urgently to reinforce the wound.

• T. True
• F. False

Answer: False

This is the opposite of what occurs. During early proliferation, fibroblasts deposit type III collagen — the emergency scaffold. Type III collagen is thinner, more loosely organized, and deposited quickly, providing early structural support but lower tensile strength. It is only during the remodeling phase (which can last months to years) that type III collagen is progressively replaced by type I collagen, which is thicker, more cross-linked, and mechanically stronger. The sequence matters clinically: wounds may feel 'healed' after proliferation but have not yet reached their maximum strength.

Question 5

Explain why the macrophage phenotype switch from inflammatory to reparative is considered the pivotal transition in wound healing, and what happens when this switch fails.

Model answer: Macrophages act as the bridge between the inflammatory and proliferative phases. After clearing debris and bacteria (inflammatory phenotype, releasing IL-1 and TNF-α), macrophages must switch to a reparative phenotype that releases VEGF and FGF. VEGF drives angiogenesis — new capillary sprouting into the wound to supply oxygen and nutrients. FGF recruits fibroblasts to begin collagen deposition. Without this switch, no growth factor signal initiates the proliferative phase: fibroblasts don't migrate in, collagen is not deposited, new vessels don't form, and granulation tissue never develops. The wound remains stuck in chronic inflammation — abundant immune cells, elevated cytokines, no healing tissue. This is the pathological state of chronic wounds seen in diabetes, venous insufficiency, and pressure ulcers.

The relay-race model makes the pivotal nature of this transition clear: the inflammatory phase hands off to the proliferative phase through the macrophage switch. If that baton is never passed, the entire subsequent sequence fails. Understanding this transition is also the clinical target for therapies like growth factor application (PDGF, VEGF) and bioengineered skin substitutes, which attempt to artificially drive the proliferative phase when the natural macrophage switch is impaired.